Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke

Journal of Neurology

Volumn 245, Issue 9, 1998, Pages 584-588

  Lampl, Yair ^a,b   Geva, Diklah ^a   Gilad, Ronit ^a,b   Eshel, Yehiel ^a,b   Ronen, Lev ^a   Sarova Pinhas, Ida ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cerebrospinal fluid magnesium; Magnesium; Stroke

Indexed keywords

MAGNESIUM;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BRAIN INFARCTION; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; HEART DISEASE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STROKE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LINEAR MODELS; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0031705667     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050249     Document Type: Article

References (21)

1. +2 in insulated human cerebral arteries. Eur J Pharmacol 119:83-89
2. Altura BM, Altura BT (1992) The role of magnesium in the etiology of strokes and cerebrovasospasm. Magnesium 1:277-291
3. +2 vs organic calcium channel blockers on myogenic tone and against induced responsiveness of blood vessels. Can J Physiol Pharmacol 65:129-145
4. Bekkers JM, Stevens CF (1993) NMDA receptors at excitatory synapses in the hypocampus: test of a theory of magnesium block. Neurosci Lett 156:73-77
5. Beneviste H, Dreger J, Schousboe A, Diemer N (1984) Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374
6. Boast C, Gerhardt S, Pastor G, Lehmann J, Etienne P, Liebmann J (1988) The N methyl D aspartate antagonist CSG-19755 and CPP reduce ischemic brain damage in gebirls. Brain Res 442:345-348
7. +2 in cultured cortical neuron. Neuron 11:751-777
8. Dubey SN, Melita RS (1975) Study of serum and cerebrospinal fluid magnesium levels in cerebrovascular accident. Neurol India 23:17-55
9. Gelmers HJ, Gorter K, De Weerdt CJ, Wiezer HJA (1988) A controlled trail of nimodipine in acute ischemic stroke. N Engl J Med 318:203-207
10. Grotto J, Picone C, Ostrow P, et al (1990) CGS 19755. A competitive NMDA receptor antagonist reduces calcium calmodulia binding and improves outcome after global cerebral ischemia. Ann Neurol 27:612-619
11. Heipert R, Eickloff K, Karsteus RH (1979) Magnesium and inorganic phosphate content in CSF related to blood brain barrier function in neurological disease. J Neurol Sci 40:87-95
12. +2 blockade of NMDA receptors. Neurosci Lett 173:75-78
13. +2 protects against PCP induced cerebrospasms and vascular damage in rat brain. Magnes Trace Elem 9:44-46
14. +2 in rat brain. Neurosci Lett 109:113-116
15. Ishii T, Myriyoshi K, Sagihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigeoto R, Mizuno N, Masu M (1993) Molecular characterization of the family of the N methyl D aspartate receptor subunit. J Biol Chem 268:2836-2843
16. Kaku D, Giffard R, Choi D (1993) Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260:1516-1518
17. Marret S, Gressens P, Gadisseax JF, Evrard P (1995) Prevention by magnesium of exitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 37:473-184
18. +2 effects on the concentrations of bovine cerbral artery. No Shinkei Geka 16:1251-1259
19. Quality Standards Subcommittee of the American Society of Neurology (1993) Practice parameters: Lumbar puncture (summary statement). Neurology 43: 625-627
20. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M (1991) Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922-927
21. Rothwan S, Olney J (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 119:105-111